Responses
Clinical science
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 29 June 2016
- Published on: 29 June 2016Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degenerationShow More
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration Dan C?lug?ru, Mihai C?lug?ru Department of Ophthalmology, Univ of Medicine Cluj-Napoca/Romania
Re: Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration. Barthelmes et al. Br J Ophthalmol published online on March 18, 2016;doi:10.1136/bjophthalmol- 20...
Conflict of Interest:
None declared.